Skip to content
PubMed This is a summary of 24 peer-reviewed journal articles Updated
Reproductive Endocrinology and Infertility · Uterine Fibroids

How Are Cavity-Distorting Fibroids Treated Before IVF?

At a Glance

Fibroids that change the shape of the uterine cavity can make embryo implantation harder and raise miscarriage risk. Imaging confirms the distortion, and surgical removal may be recommended before embryo transfer, but timing is individualized and surgery cannot guarantee pregnancy.

A fibroid that distorts the uterine cavity alters the shape of the space where an embryo must implant and grow. When a fibroid bulges into this space, it can lower the chances of embryo implantation and increase the risk of miscarriage [1][2]. Because of this, fertility specialists often recommend surgically removing clearly cavity-distorting fibroids before transferring an embryo [3][4]. However, surgery is not automatic for every patient. The decision depends heavily on the fibroid’s exact location, your symptoms, and your individual fertility timeline.

Endometrial Contact vs. True Cavity Distortion

It is important to distinguish between a fibroid that merely touches the uterine lining and one that actively changes the cavity’s shape.

  • Endometrial Contact: Some fibroids grow entirely within the muscular wall of the uterus (intramural fibroids, such as FIGO type 3) but press up against the lining (endometrium) [5][6]. The classification type alone does not dictate treatment; doctors look at the imaging to see if the fibroid merely touches the lining or if it “indents” or “deforms” it. While large or multiple intramural fibroids can sometimes impact IVF success, they do not automatically require removal, and decisions are highly individualized [7][8].
  • True Cavity Distortion: Fibroids that protrude directly into the uterine cavity (submucosal fibroids, classified as FIGO types 0, 1, and 2) actively distort its natural contour [5][6]. These are the lesions most strongly linked to fertility challenges and IVF complications [1][3].

Impact on Implantation and Miscarriage

Fibroids that disrupt the cavity create a less hospitable physical environment. Studies show that patients with cavity-distorting fibroids have lower implantation and clinical pregnancy rates during IVF compared to those with a normal, undistorted cavity [1]. They are also associated with a higher risk of early pregnancy loss (miscarriage) [2][9].

Clinical guidelines and systematic reviews suggest that removing cavity-distorting fibroids may improve clinical pregnancy rates [3][2]. However, high-quality evidence proving that surgery definitively increases live-birth rates or prevents all miscarriages remains uncertain [10][11]. Surgery is offered to optimize the chances of a successful pregnancy, but it cannot guarantee one.

How Cavity Involvement is Diagnosed

A standard transvaginal ultrasound (TVUS) is the typical first step for finding fibroids, but it may not perfectly show whether a fibroid is actively distorting the cavity [12][13]. To get a clearer picture, doctors use specialized procedures:

  • Saline Infusion Sonohysterography (SIS): Sterile saline fluid is gently introduced into the uterus during an ultrasound. The fluid separates the uterine walls, making it much easier to see if a fibroid is actively protruding into the cavity [13][14].
  • Hysteroscopy: A thin, lighted camera is passed through the cervix directly into the uterus. This directly views the inside surface of the cavity and can often treat the fibroid at the same time [15][16]. While excellent for viewing the inner cavity, it does not show the deeper muscular walls of the uterus.
  • MRI: Magnetic resonance imaging provides highly detailed pictures. It is not needed for everyone, but it is used selectively for complex cases to map the exact size, number, and depth of all fibroids before surgery [17][18].

Treatment Timing and IVF Considerations

If a fibroid is distorting your cavity, your doctor may recommend a myomectomy (surgical removal of the fibroid) to optimize your uterus before an embryo transfer [3].

  • Surgical Approaches and Risks: If the fibroid is mostly inside the cavity, it can often be removed through the cervix (hysteroscopic myomectomy) [15][19]. Deeper or larger fibroids may require abdominal or laparoscopic surgery. All surgeries carry risks, including bleeding, infection, the need for a staged (multiple-part) procedure, and the formation of scar tissue (intrauterine adhesions) [20].
  • Embryo Banking Before Surgery: Egg retrieval does not require a normal uterine cavity. Because surgery can delay treatment, patients concerned about age or declining ovarian reserve may choose to undergo IVF egg retrieval and freeze their embryos before having the fibroid removed [21]. The embryo transfer happens later, once the uterus has healed.
  • Healing and Cavity Checks: Healing takes time, and the safe interval before you can try to conceive varies by procedure. Surgeons often recommend a follow-up SIS or hysteroscopy to ensure the cavity is free of scar tissue before transferring an embryo [20][22].
  • Delivery Planning: Not all fibroid surgeries require a future Cesarean section. However, if an abdominal or laparoscopic surgery requires cutting deeply into the uterine wall and entering the cavity, a planned Cesarean may be recommended to reduce the risk of uterine rupture during labor [23][24]. Always share your operative report with your obstetrician so they can help you make a safe delivery plan.

Common questions in this guide

What is a cavity-distorting fibroid?
It is a uterine fibroid that changes the shape of the space inside the uterus, often by bulging into it. Submucosal fibroids and some intramural fibroids that indent the lining can affect embryo implantation.
Can a cavity-distorting fibroid make it harder to get pregnant or increase miscarriage risk?
Yes. These fibroids are linked with lower implantation and clinical pregnancy rates during IVF and a higher risk of early pregnancy loss, although they do not determine an individual’s outcome.
How do doctors tell whether a fibroid distorts the uterine cavity?
A transvaginal ultrasound is often the first test. Saline infusion sonohysterography or hysteroscopy can show the cavity more clearly, and MRI may be used in complex cases or for surgical planning.
Should a cavity-distorting fibroid be removed before IVF?
Fertility specialists often recommend myomectomy for a clearly cavity-distorting fibroid before embryo transfer to optimize the uterine cavity. Surgery is not automatic; the fibroid’s location, size and depth, symptoms, age, ovarian reserve, and fertility timeline are considered, and removal cannot guarantee pregnancy.
Can I freeze embryos before fibroid surgery?
Yes. Egg retrieval does not require a normal uterine cavity, so some patients retrieve eggs and freeze embryos before surgery when a treatment delay is a concern. Embryo transfer is postponed until the uterus has healed and follow-up evaluation confirms that the cavity is ready.
How long after myomectomy can I have an embryo transfer?
The safe interval varies by the type and depth of surgery, so your surgeon will set the timeline. A follow-up saline ultrasound or hysteroscopy may be recommended to check healing and scar tissue before transfer.
Will a myomectomy mean I need a Cesarean delivery?
Not always. If abdominal or laparoscopic surgery cuts deeply into the uterine wall or enters the cavity, a planned Cesarean may be recommended to lower the risk of uterine rupture; the operative report helps the obstetrician plan delivery.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on uterine corpus leiomyoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my imaging, does the fibroid actively distort or indent the shape of my uterine cavity, or does it only touch the lining?
  2. 2.Do you recommend a saline ultrasound (SIS) or diagnostic hysteroscopy to get a clearer view of the cavity before making a treatment plan?
  3. 3.If surgery is recommended, what surgical approach is best, and what are the risks of scar tissue (adhesions) forming inside my uterus?
  4. 4.Given my age and ovarian reserve, should we consider retrieving eggs and freezing embryos before I have surgery?
  5. 5.If myomectomy is performed, how long will I need to wait to heal before an embryo transfer, and will the surgical details require a planned Cesarean delivery?

References

References (24)
  1. 1

    Alterations in uterine hemodynamics caused by uterine fibroids and their impact on in vitro fertilization outcomes.

    Moon JW, Kim CH, Kim JB, et al.

    Clinical and experimental reproductive medicine 2015; (42(4)):163-8 doi:10.5653/cerm.2015.42.4.163.

    PMID: 26816875
  2. 2

    Removal of myomas in asymptomatic patients to improve fertility and/or reduce miscarriage rate: a guideline.

    ,

    Fertility and sterility 2017; (108(3)):416-425 doi:10.1016/j.fertnstert.2017.06.034.

    PMID: 28865538
  3. 3

    The management of uterine fibroids in women with otherwise unexplained infertility.

    Carranza-Mamane B, Havelock J, Hemmings R, et al.

    Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2015; (37(3)):277-285 doi:10.1016/S1701-2163(15)30318-2.

    PMID: 26001875
  4. 4

    Management of fibroids prior to in vitro fertilization/intracytoplasmic sperm injection: A pragmatic approach

    Sarıdoğan E, Sarıdoğan E

    Journal of the Turkish German Gynecological Association 2019; (20(1)):55-59 doi:10.4274/jtgga.galenos.2018.2018.0148.

    PMID: 30444214
  5. 5

    Hysteroscopic myomectomy.

    Piecak K, Milart P

    Przeglad menopauzalny = Menopause review 2017; (16(4)):126-128 doi:10.5114/pm.2017.72757.

    PMID: 29483854
  6. 6

    The challenge of FIGO type 3 leiomyomas and infertility: Exploring therapeutic alternatives amidst limited scientific certainties.

    Favilli A, Mazzon I, Etrusco A, et al.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2024; (165(3)):975-987 doi:10.1002/ijgo.15260.

    PMID: 38009829
  7. 7

    The effect of ≤6 cm sized noncavity-distorting intramural fibroids on in vitro fertilization outcomes: a systematic review and meta-analysis.

    Erden M, Uyanik E, Polat M, et al.

    Fertility and sterility 2023; (119(6)):996-1007 doi:10.1016/j.fertnstert.2023.02.018.

    PMID: 36813123
  8. 8

    The impact of FIGO type 3 fibroids on in-vitro fertilization outcomes: A nested retrospective case-control study.

    Bai X, Lin Y, Chen Y, Ma C

    European journal of obstetrics, gynecology, and reproductive biology 2020; (247()):176-180 doi:10.1016/j.ejogrb.2019.12.018.

    PMID: 32114322
  9. 9

    Association of uterine fibroids with late miscarriage: multicenter cohort study.

    Siargkas A, Del Mar Gil Mira M, Chaveeva P, et al.

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2025; (65(2)):198-205 doi:10.1002/uog.29169.

    PMID: 39894923
  10. 10

    Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities.

    Bosteels J, van Wessel S, Weyers S, et al.

    The Cochrane database of systematic reviews 2018; (12()):CD009461 doi:10.1002/14651858.CD009461.pub4.

    PMID: 30521679
  11. 11

    Surgical treatment of fibroids for subfertility.

    Metwally M, Raybould G, Cheong YC, Horne AW

    The Cochrane database of systematic reviews 2020; (1()):CD003857 doi:10.1002/14651858.CD003857.pub4.

    PMID: 31995657
  12. 12

    Ultrasonography of uterine leiomyomas.

    Woźniak A, Woźniak S

    Przeglad menopauzalny = Menopause review 2017; (16(4)):113-117 doi:10.5114/pm.2017.72754.

    PMID: 29483851
  13. 13

    Imaging for Polyps and Leiomyomas in Women With Abnormal Uterine Bleeding: A Systematic Review.

    Maheux-Lacroix S, Li F, Laberge PY, Abbott J

    Obstetrics and gynecology 2016; (128(6)):1425-1436 doi:10.1097/AOG.0000000000001776.

    PMID: 27824761
  14. 14

    Role of 3-Dimensional Sonography in the Assessment of Submucous Fibroids: A Pilot Study.

    Keizer AL, Nieuwenhuis LL, Twisk JWR, et al.

    Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 2018; (37(1)):191-199 doi:10.1002/jum.14331.

    PMID: 28777463
  15. 15

    Submucosal uterine leiomyoma with complete cystic degeneration mimicking an empty gestational sac: a case report and literature review.

    Lin S, An D, Xu Z

    Frontiers in medicine 2026; (13()):1858581 doi:10.3389/fmed.2026.1858581.

    PMID: 42433985
  16. 16

    Technology Assessment No. 12 Summary: Sonohysterography.

    Obstetrics and gynecology 2016; (128(2)):424 doi:10.1097/AOG.0000000000001584.

    PMID: 27454731
  17. 17

    Diagnosis and classification of uterine fibroids.

    Lakabi R, Harth S, Meinhold-Heerlein I, et al.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2025; (171(2)):566-573 doi:10.1002/ijgo.70538.

    PMID: 40970558
  18. 18

    Clinical signs and diagnosis of fibroids from adolescence to menopause.

    Mension E, Carmona F, Vannuccini S, Chapron C

    Fertility and sterility 2024; (122(1)):12-19 doi:10.1016/j.fertnstert.2024.05.003.

    PMID: 38729337
  19. 19

    The management of uterine leiomyomas.

    Vilos GA, Allaire C, Laberge PY, et al.

    Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2015; (37(2)):157-178 doi:10.1016/S1701-2163(15)30338-8.

    PMID: 25767949
  20. 20

    Multiple myomectomy to aid fertility treatment - surgical and fertility outcomes: a retrospective cohort study.

    Şükür YE, Saridogan E

    Facts, views & vision in ObGyn 2021; (12(4)):283-289.

    PMID: 33575677
  21. 21

    Factors associated with successful pregnancy in women of late reproductive age with uterine fibroids who undergo embryo cryopreservation before surgery.

    Takahashi N, Harada M, Tanabe R, et al.

    The journal of obstetrics and gynaecology research 2018; (44(10)):1956-1962 doi:10.1111/jog.13754.

    PMID: 30004618
  22. 22

    The epidemiology, clinical burden, and prevention of intrauterine adhesions (IUAs) related to surgically induced endometrial trauma: a systematic literature review and selective meta-analyses.

    Munro MG, Salazar CA, Bhagavath B, et al.

    Human reproduction update 2025; (31(6)):588-625 doi:10.1093/humupd/dmaf019.

    PMID: 40914965
  23. 23

    Myoma and myomectomy: Poor evidence concern in pregnancy.

    Milazzo GN, Catalano A, Badia V, et al.

    The journal of obstetrics and gynaecology research 2017; (43(12)):1789-1804 doi:10.1111/jog.13437.

    PMID: 28892210
  24. 24

    Perinatal outcomes of women undergoing cesarean delivery after prior myomectomy.

    Gimovsky AC, Frangieh M, Phillips J, et al.

    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2020; (33(13)):2153-2158 doi:10.1080/14767058.2018.1542680.

    PMID: 30373417

This page is for informational purposes only and does not constitute medical advice. Your fertility specialist and gynecologic surgeon can interpret your imaging and advise you about surgery, embryo timing, and delivery planning.